Can ischemia-modified albumin be used to differentiate between generalized seizures and pseudoseizures?

Kamasak T., TÜREDİ S., Serin H. M., MENTEŞE A., GÜNDÜZ A., ALVER A., ...More

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.47, no.1, pp.282-286, 2017 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 47 Issue: 1
  • Publication Date: 2017
  • Doi Number: 10.3906/sag-1504-105
  • Journal Name: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.282-286
  • Keywords: Ischemia-modified albumin, generalized clonic tonic, albumin, IMA/albumin, MYOCARDIAL-ISCHEMIA, ICTAL HYPOXEMIA, MARKER, BIOMARKERS, BINDING
  • Karadeniz Technical University Affiliated: Yes

Abstract

Background/aim: In recent years ischemia-modified albumin (IMA) has been suggested as a marker that can be used in differentiating nonconvulsive conditions from epilepsy. The purpose of this study was to investigate changes in IMA levels caused by generalized clonic tonic (GTC) seizures.